Results

1–10 of 377 results for AMD

Daily Imaging With Home Optical Coherence Tomography Among Treatment-Naive Neovascular Age-Related Macular Degeneration Participants
Kevin J. Blinder, MD, FASRS
Annual Meeting Talks
2023
Accuracy and Residual Volume of Commonly Used Syringes for Intravitreal Injection and the Impact on Intraocular Pressure
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2023
Safety and Tolerability of Suprachoroidal Injection of CLS-AX in Neovascular AMD Patients With Persistent Activity After Anti-VEGF Therapy
Rahul N. Khurana, MD, FASRS
Annual Meeting Talks
2023
Long-Term Efficacy and Safety of the Port Delivery System With Ranibizumab in Patients With nAMD: Results of the Portal 5-year Subgroup Analysis
David J Massop, MD
Annual Meeting Talks
2023
Subgroup Analyses of the Phase 1 DAVIO Trial of EYP-1901 Showing Reduced Treatment Burden in Wet Age-related Macular Degeneration
Philip P Storey, MD, MPH
Annual Meeting Talks
2023
ENVISION Trial 24-Week Data: Phase 2 Study of UBX1325, a New Senolytic Agent for Patients With Wet AMD
Raj K. Maturi, MD
Annual Meeting Talks
2023
Suprachoroidal Delivery of RGX-314 for Neovascular AMD Results of the Phase II AAVIATE Study
David S. Boyer, MD
Annual Meeting Talks
2023
Subretinal Delivery of RGX-314: Gene Therapy for Neovascular Age-Related Macular Degeneration
Ashkan M. Abbey, MD, FASRS, FAAO
Annual Meeting Talks
2023
Home OCT and Artificial Intelligence in Neovascular AMD
Miguel A. Busquets, MD, FACS
Annual Meeting Talks
2023
Naive SubRetinal Hemorrhage in Neovascular AMD—Pneumatic Displacement, Subretinal Air, and tPA: Subretinal vs Intravitreal Aflibercept: The NATIVE Study
Matias Iglicki, MD
Annual Meeting Talks
2023